|
Home : Unsafe Drugs : Avandia : Newsfeeds : Profit Up, Revenues Down at Glaxo Profit Up, Revenues Down at Glaxo
Pharmaceuticals sales continued to be impacted by generic competition for Valtrex, lower Avandia and pandemic flu sales. These three factors affected sales by £1 billion. Total vaccine sales declined 46%. Performance was affected by lower pandemic flu sales.
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




